Buy Rinvoq (Upadacitinib) Online From Medications Canada.

About Rinvoq (Upadacitinib)

Uses and Benefits of Rinvoq (Upadacitinib)

Rinvoq (Upadacitinib) is indicated for treating several inflammatory conditions. It is a Janus kinase (JAK) inhibitor that helps reduce inflammation in the body.

It treats adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease, and ankylosing spondylitis when one or more tumor necrosis factor (TNF) blockers did not work well or were not tolerated.

It also treats adults and children 12 years and older with moderate to severe eczema (atopic dermatitis) that is not well controlled by other pills or injections, including biologic medicines.

Additionally, it treats adults with non-radiographic axial spondyloarthritis with objective signs of inflammation when a TNF blocker did not work well or was not tolerated.

For children 2 years and older, it treats polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic arthritis when one or more TNF blockers did not work well or were not tolerated.

The safety and effectiveness of the medication in children with ankylosing spondylitis, non-radiographic axial spondyloarthritis, ulcerative colitis, or Crohn’s disease are unknown. It is also unknown if Rinvoq is safe and effective in children under 12 years with atopic dermatitis or in children under 2 years with pJIA or psoriatic arthritis.

Ingredients in Rinvoq (Upadacitinib)

The active ingredient in Rinvoq tablets is upadacitinib. Inactive ingredients in 15 mg tablets include colloidal silicon dioxide, ferrosoferric oxide, hypromellose, iron oxide red, magnesium stearate, mannitol, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, talc, tartaric acid, and titanium dioxide.

Inactive ingredients in 30 mg tablets include colloidal silicon dioxide, hypromellose, iron oxide red, magnesium stearate, mannitol, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, talc, tartaric acid, and titanium dioxide.

How to Take RIN Rinvoq VOQ (Upadacitinib)?

Follow your healthcare provider’s instructions exactly.

Take Rinvoq once a day, with or without food. Swallow Rinvoq tablets whole. Do not split, crush, or chew the tablets.

Who Should Not Take Rinvoq (Upadacitinib)?

Do not take Rinvoq if you are allergic to upadacitinib or any of the ingredients in the medication. Check the ingredient list for more details on potential allergens.

Side Effects

Common Side Effects:

• Upper respiratory infections (cold, sinus infections)
• Nausea
• Cough
• Headache
• Fever

Serious Side Effects:

• Low white blood cell counts
• Pneumonia or serious infections
• Retinal detachment or vision changes
• Increased liver enzymes
• Severe allergic reactions

This is not a complete list of possible side effects. For a complete list, ask your doctor or pharmacist.

Safety Precautions

Before you take Rinvoq, tell your healthcare provider if you have an infection, are a current or past smoker, or have had a heart attack, other heart problems, or a stroke. Inform your healthcare provider if you have liver problems, kidney problems, unexplained stomach pain, a history of diverticulitis or ulcers, or are taking NSAIDs. Additionally, let your healthcare provider know if you have low red or white blood cell counts or if you have recently received or are scheduled to receive a vaccine, as people taking Rinvoq should not receive live vaccines.

If you are pregnant or plan to become pregnant, be sure to inform your healthcare provider. Rinvoq may harm your unborn baby based on animal studies. Females who can become pregnant should have a pregnancy test before starting Rinvoq treatment and use effective birth control during treatment and for 4 weeks after the last dose. Notify your healthcare provider if you think you are pregnant or become pregnant during treatment. If you want to take Rinvoq during pregnancy, contact AbbVie Inc. at 1-800-633-9110, or the FDA at 1-800-FDA-1088, or visit www.fda.gov/medwatch to report your experience.

If you are breastfeeding or plan to breastfeed, discuss this with your healthcare provider. Rinvoq may pass into breast milk. Your healthcare provider can help you decide whether to take Rinvoq or breastfeed, but you should not breastfeed during treatment and for 6 days after your last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Rinvoq and other medicines may interact, causing side effects.

Storage Guidelines

Store Rinvoq at a temperature between 36°F and 77°F (2°C to 25°C). Keep it in its original bottle to protect it from moisture. Ensure that Rinvoq and all medications are kept out of reach of children.

FAQs

How much can I save when purchasing Rinvoq from a Canadian pharmacy versus U.S. prices?

Purchasing Rinvoq from a Canadian pharmacy can lead to major savings. At Medications Canada, the 30 mg is priced at $2,550.00 for 30 ER tablets, compared to about $8,104.00 in the U.S. You save up to 69%.

How long does it take to receive Rinvoq when ordering online?

It takes approximately 2 to 4 weeks for shipping Rinvoq after it leaves the pharmacy.

Is a prescription required to buy Rinvoq online?

Yes, a valid prescription is required to buy Rinvoq online.

What payment options are available for purchasing Rinvoq online?

We take payments by personal check, certified check, international money order, and e-check.

What is the refund or return policy for Rinvoq bought online?

Pharmaceutical laws and safety rules prevent us from accepting returns or issuing refunds for Rinvoq bought online. Always consult your doctor before ordering. Read more.

Is Rinvoq available over-the-counter?

Rinvoq is not available over the counter because it needs to be used under a doctor’s supervision. Due to the risk of serious side effects, like blood clots, a valid prescription is required to ensure safe Use.

Reference

• FDA. Rinvoq (Upadacitinib) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/211675s021s022lbl.pdf
• CDC. Crohn’s Disease Basics. https://www.cdc.gov/inflammatory-bowel-disease/about/crohns-disease-basics.html
• FDA. Rinvoq (Upadacitinib) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211675s003lbl.pdf
• GoodRx. Rinvoq Prices, Coupons & Savings Tips. https://www.goodrx.com/rinvoq?label_override=rinvoq&form=tablet&dosage=30mg&quantity=30&drugId=45892